AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 33 filers reported holding AURA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $954,641 | -47.9% | 106,426 | -28.3% | 0.00% | 0.0% |
Q2 2023 | $1,833,926 | -61.7% | 148,496 | -71.2% | 0.00% | -66.7% |
Q1 2023 | $4,788,870 | +213.0% | 516,042 | +254.2% | 0.00% | +200.0% |
Q4 2022 | $1,529,892 | -43.6% | 145,704 | -2.7% | 0.00% | -50.0% |
Q3 2022 | $2,713,000 | +55.4% | 149,740 | +21.6% | 0.00% | +100.0% |
Q2 2022 | $1,746,000 | +34820.0% | 123,188 | +56150.2% | 0.00% | – |
Q1 2022 | $5,000 | -83.9% | 219 | -87.9% | 0.00% | – |
Q4 2021 | $31,000 | – | 1,805 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $51,617,000 | 12.92% |
Matrix Capital Management Company, LP | 4,112,870 | $69,837,000 | 0.78% |
Rock Springs Capital Management LP | 1,008,114 | $17,118,000 | 0.40% |
Nantahala Capital Management | 99,146 | $1,683,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,255,480 | $21,318,000 | 0.04% |
Citadel Advisors | 2,315,102 | $37,318,000 | 0.01% |
CAAS CAPITAL MANAGEMENT LP | 10,000 | $170,000 | 0.00% |
Concord Wealth Partners | 150 | $3,000 | 0.00% |
Allianz Asset Management GmbH | 55,145 | $936,000 | 0.00% |
FMR LLC | 471,300 | $8,003,000 | 0.00% |